Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoterIMLER, J.-L; DUPUIT, F; CHARTIER, C et al.Gene therapy (Basingstoke). 1996, Vol 3, Num 1, pp 49-58, issn 0969-7128Article

Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glandsJACQUOT, J; PUCHELLE, E; DALEMANS, W et al.The European respiratory journal. 1993, Vol 6, Num 2, pp 169-176, issn 0903-1936Article

Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene productsCHRIST, M; LOUIS, B; STOECKEL, F et al.Human gene therapy. 2000, Vol 11, Num 3, pp 415-427, issn 1043-0342Article

Characterization of recombinant human factor IX expressed in transgenic mice and in derived transgenic mice and in derived transimmortalized hepatic cell linesJALLAT, S; PERRAUD, F; DALEMANS, W et al.EMBO journal (Print). 1990, Vol 9, Num 10, pp 3295-3301, issn 0261-4189, 7 p.Article

Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectorsIMLER, J.-L; CHARTIER, C; DREYER, D et al.Gene therapy (Basingstoke). 1996, Vol 3, Num 1, pp 75-84, issn 0969-7128Article

Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patientsDIETERLE, A; GRATWOHL, A; NIZZE, H et al.Transplantation. 1990, Vol 49, Num 6, pp 1093-1100, issn 0041-1337, 8 p.Article

Irradiated donor buffy coat following T cell-depleted bone marrow transplantsGARTWOHL, A; TICHELLI, A; WÜRSCH, A et al.Bone marrow transplantation (Basingstoke). 1988, Vol 3, Num 6, pp 577-582, issn 0268-3369Article

Active γ-carboxylated human factor IX expressed using recombinant DNA techniquesDE LA SALLE, H; ALTENBURGER, W; ELKAIM, R et al.Nature (London). 1985, Vol 316, Num 6025, pp 268-270, issn 0028-0836Article